Study guide
On-Site Diagnostic Services
NCCHC CCHP Certified Correctional Health Professional Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
About the CCHP Exam Application, Scoring & Testing Logistics 2026 Content Outline & Study Strategy
2 Governance: Access, Authority & Autonomy
Access to Care Responsible Health Authority & Designated Health Staff Medical Autonomy Administrative Meetings and Reports
3 Governance: Policies, CQI & Privacy
Policies and Procedures Continuous Quality Improvement (CQI) Program Confidentiality and Privacy of Care
4 Governance: Records, Death & Grievances
Health Records Procedure in the Event of a Death Grievance Process for Health Care Complaints
5 Health Promotion: Prevention Fundamentals
Healthy Lifestyle Promotion Infection Prevention and Control Clinical Preventive Services
6 Health Promotion: Surveillance, Suicide & Contraception
Medical Surveillance of Incarcerated Workers Suicide Prevention and Intervention Contraception Services
7 Health Promotion: Communication & Safety
Communication on Patients' Health Needs Patient Safety Staff Safety
8 Personnel: Credentials & Development
Credentials Clinical Peer Review and Competency Enhancement Professional Development
9 Personnel: Training & Incarcerated Workers
Health Training for Custody Staff Medication Administration Training Incarcerated Workers in Health Services
10 Personnel: Staffing, Liaison & Orientation
Staffing Health Care Liaison Orientation for Health Staff
11 Ancillary: Pharmacy, Meds, Clinic & Diagnostics
Pharmaceutical Operations Medication Administration Services Clinic Space, Equipment and Supplies On-Site Diagnostic Services
12 Ancillary: Nutrition, Emergency & Hospital Care
Nutrition Services Emergency Services and Response Plan Hospital and Specialty Care
13 Patient Care: Information & Screening Pathway
Information on Health Services Receiving Screening Transfer Screening Initial Health Assessment
14 Patient Care: MH, Oral, Requests & Protocols
Mental Health Screening and Evaluation Oral Care Nonemergency Health Care Requests and Services Nurse-Initiated Protocols and Procedures
15 Patient Care: Continuity & Discharge
Continuity, Coordination, and Quality of Care During Incarceration Discharge Planning
16 Specialized: Chronic, MH, SUD & Sexual Assault
Chronic Disease Management and Specialized Health Care Mental Health Services Services for Substance Use Disorder Response to Sexual Assault and Abuse
17 Specialized: Pregnancy, Infirmary, EOL & Gender Care
Care of the Pregnant and Postpartum Patient Infirmary-Level Care Care for the Terminally Ill Gender-Affirmative Health Care Services
18 Medical-Legal: Restraint, Housing & Forensic Roles
Restraint and Seclusion Restrictive Housing Emergency Psychotropic Medication Therapeutic Relationship, Forensic Information, and Disciplinary Actions
19 Medical-Legal: Consent, Research & Executions
Informed Consent and Right to Refuse Medical and Other Research Executions (Prisons Only)
On-Site Diagnostic Services
Key Takeaways Explain This Topic AI
On-site diagnostics include CLIA-waived testing, phlebotomy, point-of-care devices, and radiology either on-site or by reliable contract—with quality control and critical-value reporting built in.
CLIA-waived tests still require correct training, kit storage, quality checks, and result documentation; ‘waived’ does not mean ‘uncontrolled.’
Critical values must be reported promptly to a responsible licensed clinician and documented with read-back or equivalent closed-loop communication.
Clinical laboratory specimens and forensic/chain-of-custody specimens serve different purposes; processes must not confuse therapeutic care labs with evidentiary collection unless roles and consent/authority are clear.
Diagnostic access is part of access to care: unreasonable delay in indicated labs or imaging is a clinical systems failure, not only a vendor issue.
Last updated: July 2026
On-Site Diagnostic Services
Quick Answer: NCCHC-aligned diagnostic services provide timely CLIA-waived and other authorized testing, competent phlebotomy , point-of-care devices with quality control, and radiology on-site or via contract—plus critical value reporting and clear separation of clinical versus forensic/chain-of-custody specimen processes. Diagnostics exist to support clinical decisions; waived status never excuses poor quality control.
Domain IV’s on-site diagnostic services cover how jails and prisons generate objective clinical data without sending every patient out for every test. Outsourcing some tests is normal; having no workable diagnostic pathway for urgent and routine needs is not.
Scope of On-Site Diagnostics
Modality Role in corrections
CLIA-waived testing Rapid results for defined simple tests (e.g., urine hCG, some glucose, certain infectious disease screens—exact menu varies)
Phlebotomy / specimen collection Blood and other specimens for reference lab panels, therapeutic drug levels, infectious disease serologies
Point-of-care (POC) Bedside/clinic devices (glucometers, some chemistries, INR where used, urine drug screens per policy)
- Radiology X-ray (often chest, extremity) on-site or mobile/contract; advanced imaging usually hospital-based
- ECG and other basic studies As equipment and competency allow
- Reference lab courier systems Extend menu beyond waived/on-site capacity
CCHP does not require you to list every waived analyte; it requires you to know governance, quality, reporting, and access principles.
CLIA-Waived Testing: Simple Does Not Mean Casual
Under U.S. clinical laboratory regulation, waived tests are simple tests with low risk of erroneous results when performed correctly. Facilities performing testing must still:
Hold appropriate CLIA certificate type for the testing performed.
Follow manufacturer instructions exactly (timing, sample type, storage).
Train and document competency of staff who run tests.
Store kits within temperature limits; discard expired kits.
Perform required quality control and document results.
Record patient results in the health record and act on them clinically.
Avoid using waived devices beyond their approved purpose.
Exam trap: “Waived means anyone can run it with no training or QC.” False. Waived means the regulatory category is lower complexity—not that quality systems disappear.
Phlebotomy and Specimen Handling
Phlebotomy programs need:
Trained personnel (scope per license and state rules).
Patient identification procedures before draw.
Correct tubes, order of draw, labeling at bedside/chair.
Safe sharps practices and exposure response (Domain II).
Timely processing/centrifugation when required.
Courier schedules that match clinical urgency (STAT vs routine).
Tracking of lost specimens and redraw rates for CQI.
Failed draws, mislabeled specimens, and hemolyzed samples waste time and can delay HIV confirmation, INR management, or lithium levels—high-stakes errors in corrections populations.
Point-of-Care Testing
POC devices bring speed but introduce operator error and QC drift . Good programs:
Validate devices before clinical use.
Require QC at defined intervals and after certain events (new lot, dropped meter).
Lock out or flag devices that fail QC.
Correlate unexpected POC results with laboratory confirmation when clinically indicated.
Control who may perform POC testing.
Example: A glucometer reading of 42 mg/dL in a sweaty, confused patient drives immediate treatment per protocol and clinical correlation; a wildly unexpected chemistry POC result in an asymptomatic patient may need repeat/lab confirmation before irreversible decisions—context matters.
Radiology: On-Site or Contract
Facilities may operate on-site x-ray with appropriate shielding, equipment maintenance, operator credentials, and image interpretation pathways (radiologist read vs credentialed on-site interpretation per policy and law). Others use mobile radiology or routine transport/contract arrangements.
Access expectations
Indicated imaging is obtainable in a clinically appropriate timeframe (e.g., rule-out fracture, evaluation of acute chest findings per clinical judgment—not “eventually someday”).
Results return to the ordering clinician with documentation.
Urgent/emergent imaging needs integrate with hospital/emergency pathways (Domain IV hospital and specialty care).
Pregnancy status considerations and shielding practices are followed.
Custody transport plans do not create automatic multi-week delays for indicated studies without clinical risk assessment and alternatives.
Radiology is part of diagnostic services even when the beam is off-site; the standard is functional access , not ownership of a machine for its own sake.
Quality Control
Quality control (QC) is the set of activities that detect problems before (or as) they affect patients:
Reagents and controls run as required.
Instrument calibration and maintenance (biomed interface).
Proficiency testing where applicable for non-waived testing.
Temperature logs for reagent refrigerators.
Review of QC failures with service removal until corrected.
Correlation studies when changing methods.
QC failures should stop patient testing on that method until resolved—not be overridden casually to “clear the list.”
Critical Value Reporting
A critical value (panic value) is a result so far outside expected range that it may indicate a life-threatening situation requiring prompt clinical attention (exact lists are lab/medical-director defined—e.g., extremely high/low potassium, critical INR, markedly low glucose on lab confirmation pathways, serious infectious results as defined).
Closed-loop communication
Lab or testing personnel identify critical result per policy.
Immediate notification to a responsible licensed clinician (not only leaving a sticky note).
Read-back or equivalent verification of the value and patient identity.
Documentation of who was notified, when, and what read-back occurred.
Clinician assessment and action (treat, repeat, transfer, monitor).
Escalation if the responsible clinician cannot be reached within defined timeframes.
Critical values sitting unread in an electronic in-basket overnight without coverage rules are a systems failure. Link to after-hours coverage and on-call structures.
Forensic Specimens vs Clinical Labs
Corrections settings sometimes collect specimens for clinical care and, separately, for forensic or disciplinary purposes (e.g., evidentiary sexual-assault kits handled under PREA/SANE pathways, court-ordered testing, chain-of-custody urine for non-therapeutic uses). CCHP-relevant distinctions:
- Dimension Clinical laboratory testing Forensic / chain-of-custody testing
- Purpose Diagnose/treat the patient Evidence, legal, or non-therapeutic policy use
Consent/authority Clinical consent/implied for treatment contexts as applicable Often specific legal authority, warrant, or distinct consent rules
Handling Standard clinical labeling and lab transport Documented chain of custody , seals, restricted access
Role of health staff Therapeutic relationship primary May create conflicts if same staff collect for punishment without role clarity
Records Health record May involve separate evidentiary records
Teaching point: Therapeutic care should not be compromised to serve forensic goals, and health staff should understand when they are acting in a clinical versus forensic capacity (Domain VII therapeutic relationship / forensic information interfaces). Sexual assault evidence collection follows specialized protocols and advocacy interfaces (Domain VI), not casual clinic urine-cup handling.
Do not treat a routine clinical urine culture and a chain-of-custody drug screen as identical processes.
Diagnostic Access as Access to Care
Diagnostic delays cause treatment delays. High-risk patterns:
No weekend or holiday plan for critically needed labs.
Chronic courier failures without backup.
Radiology contract lapses.
Restrictive housing patients skipped for phlebotomy without clinical plan.
Results filed without clinician review (especially critical and actionable infectious results).
CQI should track turnaround times, critical-value compliance, redraw rates, and outside-trip delays for diagnostics.
Staff Competency and Safety
Only trained, authorized personnel perform invasive collections and operate devices. Exposure control plans, sharps safety, and specimen transport bags that contain leaks protect staff (Domain II staff safety). Patients with behavioral dysregulation may need clinical-custody coordination for safe phlebotomy—not punitive cancellation of all labs indefinitely without a plan.
Common CCHP Traps
Believing CLIA-waived tests need no training, QC, or documentation.
Confusing presence of a glucometer with a complete diagnostic program.
Leaving critical values as voicemail without read-back/closure.
Using clinical blood draws for forensic purposes without proper authority/process.
Assuming off-site radiology means no responsibility for timely access.
Filing abnormal results without ensuring a clinician acts.
Bottom Line for the Exam
On-site diagnostic services succeed when tests are indicated, correctly performed, quality-controlled, communicated, and acted on , with clear lines between care and forensic collection. Choose answers that close the loop from specimen to clinical action and that keep waived testing inside a real quality system.